CRYOPORT, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
CRYOPORT, INC. (CYRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-08-06
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2026-03-31 was 0.00%.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-03-31 was 0.00%.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-03-31 was 0.00%.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00% 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 0.00% 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | 0.00% 10-K · filed 2026-03-05 | |||
| 2025-09-30 | 0.00% 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 0.00% 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | 0.00% 10-Q · filed 2026-05-05 | |||
| 2024-12-31 | 0.00% 10-K · filed 2026-03-05 | |||
| 2024-09-30 | 0.00% 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | 0.00% 10-Q · filed 2025-08-12 | |||
| 2024-03-31 | 0.00% 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | 0.00% 10-K · filed 2026-03-05 | |||
| 2023-09-30 | 0.00% 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | 0.00% 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | 0.00% 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | 0.00% 10-K · filed 2025-03-07 | |||
| 2022-09-30 | 0.00% 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | 0.00% 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | 0.00% 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | 0.00% 10-K · filed 2024-03-13 | |||
| 2021-09-30 | 0.00% 10-Q · filed 2022-11-04 | |||
| 2021-06-30 | 0.00% 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | 0.00% 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | 0.00% 10-K · filed 2023-02-28 | |||
| 2020-09-30 | 0.00% 10-Q · filed 2020-11-06 | |||
| 2020-06-30 | 0.00% 10-Q · filed 2020-08-10 | |||
| 2020-03-31 | 0.00% 10-Q · filed 2020-05-08 | |||
| 2019-12-31 | 0.00% 10-K · filed 2022-02-28 | |||
| 2019-09-30 | 0.00% 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | 0.00% 10-Q · filed 2019-08-09 | |||
| 2019-03-31 | 0.00% 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | 0.00% 10-K · filed 2020-03-10 | |||
| 2017-12-31 | 0.00% 10-K · filed 2019-03-13 | |||
| 2015-03-31 | 0.00% 10-K · filed 2015-05-19 | |||
| 2014-06-30 | 0.00% 10-Q · filed 2014-07-31 | |||
| 2014-03-31 | 0.00% 10-K · filed 2015-05-19 | |||
| 2013-12-31 | 0.00% 10-Q · filed 2014-02-13 | |||
| 2013-09-30 | 0.00% 10-Q · filed 2013-11-18 | |||
| 2013-06-30 | 0.00% 10-Q · filed 2013-08-14 | |||
| 2013-03-31 | 0.00% 10-K · filed 2013-06-25 | |||
| 2012-12-31 | 0.00% 10-Q · filed 2014-02-13 | |||
| 2012-09-30 | 0.00% 10-Q · filed 2013-11-18 | |||
| 2012-06-30 | 0.00% 10-Q · filed 2013-08-14 | |||
| 2012-03-31 | 0.00% 10-K · filed 2013-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |